LIH priority research topics
LIH aims to perform research that transcends the classical boundaries of individual diseases and that can be tangibly applied in the clinical practice to address unmet needs, thus positively affecting health outcomes for patients.
This translational and transversal research strategy is accompanied by the increasing appreciation of the role of the immune system in determining the balance between health and disease, implying that immune-related disorders share common mechanisms of action. These considerations have led LIH to centre its research activities on three key priority areas – cancer, immunological disorders and neurodegenerative diseases.
LIH has built up a strong expertise in selected cancer types, including brain cancer, haematological malignancies and gastro-intestinal cancers.
LIH also builds on ongoing work in allergy research to understand the early onset, impact of environmental factors and predisposition to diseases with a strong immunological component and apply these insights to additional chronic immunological illnesses.
In terms of neurodegeneration, LIH leverages on the expertise gained through the FNR-funded National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD), in collaboration with the Luxembourg Centre for Systems Biomedicine (LCSB), to further investigate the role of the immune system and of the brain-body axis in the pathogenesis and progression of Parkinson’s Disease and Multiple Sclerosis.
Click on a priority area to learn more about the topic and dedicated LIH research groups and to access all related news, events and job opportunities.